In vivo angiogenic activity of neuroblastoma correlates with MYCN oncogene overexpression

International Journal of Cancer

Volumn 102, Issue 4, 2002, Pages 351-354

  Ribatti, Domenico ^a,c   Raffaghello, Lizzia ^b   Pastorino, Fabio ^b   Nico, Beatrice ^a   Brignole, Chiara ^b   Vacca, Angelo ^a   Ponzoni, Mirco ^b  

^a UNIVERSITY OF BARI   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c POLICLINICO   (Italy)

Author keywords

Angiogenesis; Chorioallantoic membrane; MYCN; Neuroblastoma

Indexed keywords

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MODEL; CHICK EMBRYO; CHILD; CHORIOALLANTOIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INFANT; MALE; MOUSE; NEUROBLASTOMA; NONHUMAN; NUDE MOUSE; ONCOGENE; ONCOGENE MYC; ONCOGENE MYCN; OUTCOMES RESEARCH; PRIORITY JOURNAL; SOLID TUMOR; TUMOR BIOPSY; XENOGRAFT;

ADOLESCENT; ALLANTOIS; ANIMALS; BIOPSY; CHICK EMBRYO; CHILD; CHILD, PRESCHOOL; CHORION; CULTURE MEDIA, CONDITIONED; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICE; MICE, NUDE; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0036888460     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10742     Document Type: Article

References (31)

1. Maris JM, Matthay KK. Molecular biology of neuroblastoma. J Clin Oncol 1999;17:2264-79.
2. Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD, White PS. Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol 1997;19:93-101.
3. Brodeur GM. Schwann cells as antineuroblastoma agents. N Engl J Med 1996;334:1537-9.
4. Brodeur GM, Seeger RC, Schwab M, Varmus H, Bishop JM. Amplification of N-Myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224:1121-4.
5. Seeger RC, Brodeur GM, Sather H, Dalton A, Stege SE, Wong KY, Hammond D. Association of multiple copies of N-Myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985;313: 1111-6.
6. Grady-Leopardi E, Schwab B, Ablin A, Rosenau A. Detection of N-myc oncogene expression in human neuroblastoma by in situ hybridization and blot analysis: Relationship to clinical outcome. Cancer Res 1986;46:3196-9.
7. Bordow SB, Norris MD, Haber PS, Marshall GM, Haber M. Prognostic significance of MYCN oncogene expression in childhood neuroblastoma. J Clin Oncol 1998;16:3286-94.
8. Ribatti D, Vacca A, Nico B, De Falco G, Montaldo PG, Ponzoni M. Angiogenesis and anti-angiogenesis in neuroblastoma. Eur J Cancer 2002;38:750-7.
9. Stanton BL, Parada LF. The N-myc proto-oncogene: Developmental expression and in vivo site-directed mutagenesis. Brain Pathol 1992; 2:71-83.
10. Matsunaga T, Takahashi N, Ohnuma N, Tanabe M, Yoshida J, Iwai H, Shirasawa B, Shimizu B. Expression of N-myc and c-src protooncogenes correlating to the undifferentiated phenotype and prognosis of primary neuroblastomas. Cancer Res 1991;51:3148-52.
11. Negroni A, Scarpa S, Romeo A, Ferrari S, Modesti A, Raschella G. Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line. Cell Growth Differ 1991;2:511-8.
12. Schmidt ML, Salwen HR, Manohar CF, Ikegaki N, Cohn, SL. The biologic effects of antisense N-myc expression in human neuroblastoma. Cell Growth Differ 1994;5:171-8.
13. Schweigerer L, Breit S, Wenzel A, Tsunamoto K, Ludwig R, Schwab M. Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: Evidence for induction of autocrine growth activity. Cancer Res 1990;50:4411-6.
14. Meitar D, Crawford SE, Rademaker AW, Cohn SL. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J Clin Oncol 1996;14:405-14.
15. Breit S, Ashman K, Wilting J, Rossler J, Hatzi E, Fotsis T, Schweigerer L. The N-myc oncogene in human neuroblastoma cells: Down-regulation of an angiogenesis inhibitor identified as activin-A. Cancer Res 2000;60:4596-601.
16. Canete A, Navarro S, Bermudez J, Pellin A, Castel V, Llombrat-Busch A. Angiogenesis in neuroblastoma: Relationship to survival and other prognostic factors in a cohort of neuroblastoma patients. J Clin Oncol 2000;18:27-34.
17. Ribatti D, Nico B, Vacca A, Roncali L, Burri PH, Djonov V. Chorioallantoic membrane capillary bed: A useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat Rec 2001;264:317-24.
18. Brodeur GM, Pritchard J, Berthold F, Carlsen, NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F. Revisions of the international criteria for neuroblastoma. Diagnosis, staging and response to treatment. J Clin Oncol 1993;11:1466-77.
19. Matsushima M, Bogenmann E. Bi-modal differentiation pattern in a new human neuroblastoma cell line in vitro. Int J Cancer 1992;51: 250-8.
20. Biedler JL, Helsan L, Spengler BA. Morphology and growth, tumorigenicity and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 1973;33:2643-52.
21. Gross N, Favre S, Beck D, Meyer M. Differentiation-related expression of adhesion molecules and receptors on human neuroblastoma tissues, cell lines and variants. Int J Cancer 1992;52:85-91.
22. Ponzoni M, Bocca P, Chiesa V, Decensi A, Pistoia V, Raffaghello L, Rozzo C, Montaldo PG. Differential effects of N-(4-hydroxyphenyl) retinamide and retinoic acid on neuroblastoma cells: Apoptosis versus differentiation. Cancer Res 1995;55:853-61.
23. Ribatti D, Alessandri G, Vacca A, Iurlaro M, Ponzoni M. Human neuroblastoma cells produce extracellular matrix-degrading enzymes, induce endothelial cell proliferation and are angiogenic in vivo. Int J Cancer 1998;77:449-54.
24. Bogenmann EA. Metastatic neuroblastoma model in SCID mice. Int J Cancer 1996;67:381-6.
25. Ribatti D, Gualandris A, Bastaki M, Vacca A, Iurlaro M, Roncali L, Presta M. New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: The gelatin sponge/chorioallantoic membrane assay. J Vasc Res 1997;34:455-63.
26. Ribatti D, Surico G, Vacca A, De Leonardis F, Lastilla G, Montaldo PG, Rigillo N, Ponzoni M. Angiogenesis extent and expression of metalloproteinase-2 and -9 correlate with progression of human neuroblastoma. Life Sci 2001;68:1161-8.
27. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-64.
28. Fotsis T, Breit S, Lutz W, Rossler J, Hatzi E, Schwab M, Schweigerer L. Downregulation of endothelial cell growth inhibitors by enhanced MYCN oncogene expression in human neuroblastoma cells. Eur J Biochem 1999;263:757-64.
29. Kerbel RS, Viloria-Petit A, Okada F, Rak J. Establishing a link between oncogenes and tumor angiogenesis. Mol Med 1998;4:286-95.
30. Ngo CV, Gee M, Akhtar N, Yu D, Volpert O, Auerbach R, Thomas-Tikhonenko A. An in vivo function for the transforming Myc protein: Elicitation of the angiogenic phenotype. Cell Growth Differ 2000;11: 201-10.
31. Brandvold KA, Neiman P, Ruddell A. Angiogenesis is an early event in the generation of myc-induced lymphomas. Oncogene 2000;19: 2780-5.